论文信息 - Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis: reply - 字舞流文

Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis: reply

M. Naik | C. Derk | S. Schulz | M. Shenin | E. Grace | W. Xiong

[1] S. Inokuma,et al. Comment on: Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis: reply , 2010 .

[2] A. Silman,et al. Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis. , 2010, Rheumatology.

[3] A. Silman,et al. Observational Study of Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis , 2010, The Journal of Rheumatology.

[4] M. Naik,et al. A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis. , 2009, Rheumatology.

[5] U. Müller-Ladner,et al. Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database , 2008, Annals of the rheumatic diseases.